Abstract

BackgroundDespite the intensive efforts to improve the diagnosis and therapy of sepsis over the last decade, the mortality of septic shock remains high and causes substantial socioeconomical burden of disease. The function of immune cells is time-of-day-dependent and is regulated by several circadian clock genes. This study aims to investigate whether the rhythmicity of clock gene expression is altered in patients with septic shock.MethodsThis prospective pilot study was performed at the university hospital Charité–Universitätsmedizin Berlin, Department of Anesthesiology and Operative Intensive Care Medicine (CCM, CVK). We included 20 patients with septic shock between May 2014 and January 2018, from whom blood was drawn every 4 h over a 24-h period to isolate CD14-positive monocytes and to measure the expression of 17 clock and clock-associated genes. Of these patients, 3 whose samples expressed fewer than 8 clock genes were excluded from the final analysis. A rhythmicity score SP was calculated, which comprises values between -1 (arrhythmic) and 1 (rhythmic), and expression data were compared to data of a healthy study population additionally.Results77% of the measured clock genes showed inconclusive rhythms, i.e., neither rhythmic nor arrhythmic. The clock genes NR1D1, NR1D2 and CRY2 were the most rhythmic, while CLOCK and ARNTL were the least rhythmic. Overall, the rhythmicity scores for septic shock patients were significantly (p < 0.0001) lower (0.23 ± 0.26) compared to the control group (12 healthy young men, 0.70 ± 0.18). In addition, the expression of clock genes CRY1, NR1D1, NR1D2, DBP, and PER2 was suppressed in septic shock patients and CRY2 was significantly upregulated compared to controls.ConclusionMolecular rhythms in immune cells of septic shock patients were substantially altered and decreased compared to healthy young men. The decrease in rhythmicity was clock gene-dependent. The loss of rhythmicity and down-regulation of clock gene expression might be caused by sepsis and might further deteriorate immune responses and organ injury, but further studies are necessary to understand underlying pathophysiological mechanisms.Trail registration Clinical trial registered with www.ClinicalTrials.gov (NCT02044575) on 24 January 2014.

Highlights

  • Despite the intensive efforts to improve the diagnosis and therapy of sepsis over the last decade, the mortality of septic shock remains high and causes substantial socioeconomical burden of disease

  • Human leucocyte antigen-D related on monocytes serves as a reliable biomarker for immune function and immunosuppression, since it correlates with immune competence, occurrence of nosocomial infections and mortality [2, 5, 8, 9]

  • 3 patients were excluded from further analysis, since their samples expressed fewer than 8 clock genes

Read more

Summary

Introduction

Despite the intensive efforts to improve the diagnosis and therapy of sepsis over the last decade, the mortality of septic shock remains high and causes substantial socioeconomical burden of disease. In adult intensive care units (ICUs), sepsis and septic shock are the leading causes of death [2]. Lachmann et al Ann. Intensive Care (2021) 11:64 mortality, there is an urgent need towards targeted sepsis therapy addressing individual disease trajectories [3]. The further course of sepsis is presented as either a recovery to immune homeostasis, or the persistence of CARS with severe immunosuppression [5,6,7]. In the phase of severe immunosuppression, viral reactivations or opportunistic infections occur frequently and account for the majority of all sepsis-related deaths, which can occur years after hospitalization [2, 8]. Human leucocyte antigen-D related on monocytes (mHLA-DR) serves as a reliable biomarker for immune function and immunosuppression, since it correlates with immune competence, occurrence of nosocomial infections and mortality [2, 5, 8, 9]

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call